EMERALD MUTUAL FUND ADVISERS TRUST - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$13,808,065
-32.0%
387,323
-12.0%
0.83%
-24.3%
Q2 2023$20,303,704
+30.3%
440,141
+13.3%
1.10%
+19.7%
Q1 2023$15,579,973
+33.0%
388,528
+53.7%
0.92%
+26.7%
Q4 2022$11,714,633
+18.8%
252,852
+6.1%
0.73%
+16.5%
Q3 2022$9,864,000
-0.6%
238,204
+43.2%
0.62%
+8.3%
Q2 2022$9,924,000
-25.0%
166,338
-8.7%
0.58%
-1.7%
Q1 2022$13,232,000
-34.6%
182,204
-24.3%
0.58%
-18.1%
Q4 2021$20,246,000
+120.4%
240,769
+136.3%
0.71%
+124.5%
Q3 2021$9,188,000
-57.0%
101,877
-54.5%
0.32%
-54.5%
Q2 2021$21,366,000
-21.5%
224,082
-6.3%
0.70%
-22.6%
Q1 2021$27,215,000
-10.0%
239,023
+9.4%
0.90%
-14.2%
Q4 2020$30,232,000
+62.5%
218,390
-17.4%
1.05%
+18.9%
Q4 2016$18,600,000
-0.9%
264,5460.0%0.88%
-7.3%
Q3 2016$18,767,000
+250.4%
264,546
+405.8%
0.96%
+130.7%
Q2 2015$5,356,000
+46.8%
52,305
-14.7%
0.41%
+38.5%
Q1 2015$3,649,000
-10.7%
61,325
-34.1%
0.30%
-15.8%
Q4 2014$4,085,000
+72.5%
93,105
+122.5%
0.36%
+56.4%
Q3 2014$2,368,000
+51.9%
41,846
+20.5%
0.23%
+58.7%
Q2 2014$1,559,000
+41.6%
34,734
+54.2%
0.14%
+36.2%
Q1 2014$1,101,00022,5300.10%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders